Alkermes (ALKS) Operating Leases (2019 - 2026)
Alkermes (ALKS) posted quarterly Operating Leases of $62.0 million for Q2 2026, down 6.4% year-over-year from $66.2 million in Q2 2025, and down 2.78% quarter-over-quarter from $63.7 million in Q1 2026.
Alkermes (ALKS) Operating Leases (2019 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Operating Leases for 8 consecutive years, with $62.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Leases fell 6.4% year-over-year to $62.0 million; the TTM figure through Jun 2026 stood at $62.0 million (down 6.4% YoY), while the FY2025 annual figure was $63.3 million, down 8.82% from the prior year.
- Operating Leases slipped to $62.0 million in Q2 2026 per ALKS's latest filing, from $63.7 million in the prior quarter.
- Across five years, Operating Leases topped out at $104.0 million in Q1 2022 and bottomed at $62.0 million in Q2 2026.
- Historically, Operating Leases has averaged $76.3 million across 5 years, with a median of $73.3 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Leases declined 26.76% — and 2023, when it retreated 0.76%.
- Alkermes' Operating Leases stood at $76.3 million in 2022, then retreated by 0.76% to $75.7 million in 2023, then decreased by 8.37% to $69.4 million in 2024, then decreased by 8.82% to $63.3 million in 2025, then declined by 2.02% to $62.0 million in 2026.
- Business Quant data shows ALKS's Operating Leases at $62.0 million in Q2 2026, $63.7 million in Q1 2026, and $63.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.98 Mn |
| Mar 31, 2026 | 63.75 Mn |
| Dec 31, 2025 | 63.25 Mn |
| Sep 30, 2025 | 64.97 Mn |
| Jun 30, 2025 | 66.22 Mn |
| Mar 31, 2025 | 67.81 Mn |
| Dec 31, 2024 | 69.37 Mn |
| Sep 30, 2024 | 71.03 Mn |
| Jun 30, 2024 | 72.54 Mn |
| Mar 31, 2024 | 74.10 Mn |
| Dec 31, 2023 | 75.71 Mn |
| Sep 30, 2023 | 78.55 Mn |
| Jun 30, 2023 | 82.34 Mn |
| Mar 31, 2023 | 86.11 Mn |
| Dec 31, 2022 | 76.29 Mn |
| Sep 30, 2022 | 95.73 Mn |
| Jun 30, 2022 | 99.83 Mn |
| Mar 31, 2022 | 104.01 Mn |
| Dec 31, 2021 | 104.16 Mn |
| Sep 30, 2021 | 107.86 Mn |